Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair
Science Advances · 14.03.2025 · 11 (11)
DOI: 10.1126/sciadv.adt1241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.03.2025. Verfasst von Jui-Chung Chiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, U…. Hauptthemen laut MEDLINE: Recombinational DNA Repair, Lung Neoplasms, Lipoylation, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Lung cancer exhibits altered metabolism, influencing its response to radiation. To investigate the metabolic regulation of radiation response, we conducted a comprehensive, metabolic-wide CRISPR-Cas9 loss-of-function screen using radiation as selection pressure in human non–small cell lung cancer. Lipoylation emerged as a key metabolic target for radiosensitization, with lipoyltransferase 1 (LIPT1) identified as a top hit. LIPT1 covalently conjugates mitochondrial 2-ketoacid dehydrogenases with lipoic acid, facilitating enzymatic functions involved in the tricarboxylic acid cycle. Inhibiting lipoylation, either through genetic LIPT1 knockout or a lipoylation inhibitor (CPI-613), enhanced tumor control by radiation. Mechanistically, lipoylation inhibition increased 2-hydroxyglutarate, leading to H3K9 trimethylation, disrupting TIP60 recruitment and ataxia telangiectasia mutated (ATM)–mediated DNA damage repair signaling, impairing homologous recombination repair. In summary, our findings reveal a critical role of LIPT1 in regulating DNA damage and chromosome stability and may suggest a means to enhance therapeutic outcomes with DNA-damaging agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Howard Hughes Medical Institute, Eugene McDermott Center for Human Growth and Development, and Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.
- Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Hamon Center for Therapeutic Oncology Research, Departments of Internal Medicine and Pharmacology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Jui-Chung Chiang, Zengfu Shang, Tracy Rosales, Wei-Min Chen, Feng Cai, Hieu Vu, John D Minna, Min Ni, Anthony J Davis, Robert D Timmerman, Ralph J DeBerardinis, Yuanyuan Zhang
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Chiang, J. C., Shang, Z., Rosales, T., Cai, L., Chen, W. M., Cai, F., Vu, H., Minna, J. D., Ni, M., Davis, A. J., Timmerman, R. D., DeBerardinis, R. J., & Zhang, Y. (2025). Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair. Science Advances, 11(11). https://doi.org/10.1126/sciadv.adt1241
Vancouver
Chiang JC, Shang Z, Rosales T, Cai L, Chen WM, Cai F, et al. Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair. Science Advances. 2025;11(11). doi:10.1126/sciadv.adt1241
BibTeX
@article{Chiang2025,
author = {Chiang, Jui-Chung and Shang, Zengfu and Rosales, Tracy and Cai, Ling and Chen, Wei-Min and Cai, Feng and Vu, Hieu and Minna, John D and Ni, Min and Davis, Anthony J and Timmerman, Robert D and DeBerardinis, Ralph J and Zhang, Yuanyuan},
title = {Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {11},
doi = {10.1126/sciadv.adt1241}
}
EUVIMED